Aisling Capital Management LP Long-Term Concentrated

CIK: 0001766721 · Show all filings

Period: Q1 2019 (← Previous) (Next →)

Filing Date: May 20, 2019

Total Value ($000): $131,269 (100.0% shares, 0.0% debt)

Holdings (12)

— Eidos Therapeutics, Inc. (EIDIX) 20.1%

Value ($000) $26,349 Shares 1,123,630 Est. Cost $13.76 Unrealized —

— AVROBIO, Inc. (AVRO) 13.6%

Value ($000) $17,905 Shares 811,998 Est. Cost $17.15 Unrealized —

— ObsEva SA (OBSV) 13.5%

Value ($000) $17,731 Shares 1,386,338 Est. Cost $12.66 Unrealized —

— Biohaven Pharmaceutical Holding Company Ltd. (BHVN) 10.8%

Value ($000) $14,129 Shares 274,513 Est. Cost $36.98 Unrealized —

— Marker Therapeutics, Inc. (MRKR) 10.1%

Value ($000) $13,200 Shares 2,000,000 Est. Cost $5.55 Unrealized —

— Aeglea Biotherapeutics Inc (AGLE) 7.5%

Value ($000) $9,828 Shares 1,220,911 Est. Cost $7.65 Unrealized —

— Sunesis Pharmaceuticals, Inc. (SNSS) 7.0%

Value ($000) $9,234 Shares 7,600,000 Est. Cost $0.94 Unrealized —

— Zosano Pharma Corporation (ZSAN) 5.8%

Value ($000) $7,632 Shares 1,600,000 Est. Cost $2.12 Unrealized —

— Nabriva Therapeutics plc (NBRV) 3.4%

Value ($000) $4,415 Shares 1,809,259 Est. Cost $1.46 Unrealized —

RCUS Arcus Biosciences, Inc. (RCUS) 3.2%

Value ($000) $4,163 Shares 333,333 Est. Cost $11.67 Unrealized -7.0%

ACRS Aclaris Theraputics Inc (ACRS) 2.9%

Value ($000) $3,800 Shares 634,455 Est. Cost $10.31 Unrealized -35.7%

— Verona Pharma plc (VRNA) 2.2%

Value ($000) $2,883 Shares 443,596 Est. Cost $9.65 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	Eidos Therapeutics, Inc. (EIDIX)	1,123,630	$26,349	20.1%	$13.76	—	COM	28249H104
—	AVROBIO, Inc. (AVRO)	811,998	$17,905	13.6%	$17.15	—	COM	05455M100
—	ObsEva SA (OBSV)	1,386,338	$17,731	13.5%	$12.66	—	COM	H5861P103
—	Biohaven Pharmaceutical Holding Company Ltd. (BHVN)	274,513	$14,129	10.8%	$36.98	—	COM	G11196105
—	Marker Therapeutics, Inc. (MRKR)	2,000,000	$13,200	10.1%	$5.55	—	COM	57055L107
—	Aeglea Biotherapeutics Inc (AGLE)	1,220,911	$9,828	7.5%	$7.65	—	COM	00773J103
—	Sunesis Pharmaceuticals, Inc. (SNSS)	7,600,000	$9,234	7.0%	$0.94	—	COM	867328700
—	Zosano Pharma Corporation (ZSAN)	1,600,000	$7,632	5.8%	$2.12	—	COM	98979H202
—	Nabriva Therapeutics plc (NBRV)	1,809,259	$4,415	3.4%	$1.46	—	SHS	G63637105
RCUS	Arcus Biosciences, Inc. (RCUS)	333,333	$4,163	3.2%	$11.67	-7.0%	COM	03969F109
ACRS	Aclaris Theraputics Inc (ACRS)	634,455	$3,800	2.9%	$10.31	-35.7%	COM	00461U105
—	Verona Pharma plc (VRNA)	443,596	$2,883	2.2%	$9.65	—	COM	925050106